The Increasing Prevalence of Neurological Disorders Is Driving EEG (Electroencephalography) Devices Market Growth
EEG (Electroencephalography) Devices Market
EEG
(Electroencephalography) Devices Market, by Device Type (8-Channel EEG,
21-Channel EEG, 32-Channel EEG, 64-Channel EEG, and Others), by Modality
(Standalone and Portable), by End User (Hospitals, Diagnostic Centers, and
Others), and by Geography - Size, Share, Outlook, and Opportunity Analysis,
2019 - 2027.
Market Overview:
Electroencephalography
(EEG) is a non-invasive diagnostic test that records electrical activity in the
brain using electrodes placed on the scalp. It measures the electrical signals
produced by the neurons in the brain and can be used to diagnose neurological
disorders such as epilepsy, sleep disorders, and brain tumors. EEG can also be
used to monitor brain activity during surgery or to study brain function in
research settings. The EEG recording shows a visual representation of the
electrical activity of the brain, called an EEG waveform, which is used by
medical professionals to interpret the results and diagnose neurological
conditions. EEG is a safe and painless procedure that is widely used in
clinical practice.
Competitive Landscape:
Major
players operating in the global
EEG (Electroencephalography) devices market include Nihon Kohden
Corporation, EB Neuro S.p.A., NeuroWave Systems Inc., Electrical Geodesics,
Inc., Elekta AB, Neurosoft Ltd., Natus Medical Incorporated, Compumedics
Limited, and Cadwell Laboratories Inc.
Key Market Drivers:
The
increasing prevalence of neurological disorders, the rising geriatric
population, and technological advancements are some of the major drivers of the
global EEG (Electroencephalography) devices market. For instance, according to
the World Health Organization (WHO) by 2030, 1 in every 6 people globally will
be 60 years or more.
Moreover,
the increasing awareness about the benefits of EEG devices in the diagnosis and
treatment of various neurological disorders is expected to boost the growth of
the global EEG (Electroencephalography) devices market. Additionally, the growing
demand for home-based EEG devices is expected to drive the market.
Covid-19 Impact Analysis:
The
COVID-19 pandemic has had a mixed impact on the global
EEG (Electroencephalography) devices market. On one hand, the pandemic
has led to a surge in demand for EEG devices, as hospitals and clinics are
using them to monitor the brain activity of COVID-19 patients. For instance, in
March 2022, Interaxon Inc. introduced a new VR Software Development Kit (SDK),
which is EEG headband compatible.
Key Takeaways:
·
North America is
expected to dominate the growth of the global EEG (Electroencephalography)
devices market, owing to the presence of well-established healthcare
infrastructure and the increasing prevalence of neurological disorders. For
instance, in September 2022, Ceribell, Inc. got the approval of the United
States Food and Drug Administration (FDA) for its delirium indication.
·
The Asia Pacific
region is estimated to witness high growth in the global EEG
(Electroencephalography) devices market, owing to the increasing awareness
about neurological disorders and the rising geriatric population in the region.
For instance, according to the World Health Organization, there are around 104
million geriatric individuals in India (60+ years).
Comments
Post a Comment